Article

Basic answers to complicated questions for the course of chronic hepatitis C treatment.

Department of Gastroenterology, Ankara University School of Medicine, Ankara, Turkey.
Expert review of gastroenterology & hepatology 06/2012; 6(3):371-82. DOI:10.1586/egh.12.16 pp.371-82
Source: PubMed

ABSTRACT Hepatitis C virus infection is a long-lasting disease, which causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma, thus leading to liver-related death. Currently, the optimal treatment for chronic hepatitis C infection is the combination of pegylated interferon and ribavirin. The aim of this review is to assess the long-term clinical outcomes of interferons alone or in combination with ribavirin in the management of chronic hepatitis C.

0 0
 · 
0 Bookmarks
 · 
58 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

causes chronic hepatitis
 
chronic hepatitis C
 
chronic hepatitis C infection
 
Hepatitis C virus infection
 
hepatocellular carcinoma
 
liver cirrhosis
 
liver-related death
 
long-lasting disease
 
long-term clinical outcomes
 
pegylated interferon